Amedisys, Inc. (NASDAQ:AMED) is ClearAlpha Technologies LP's 8th Largest Position

ClearAlpha Technologies LP lowered its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 23.4% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 59,653 shares of the health services provider's stock after selling 18,208 shares during the quarter. Amedisys accounts for approximately 3.7% of ClearAlpha Technologies LP's portfolio, making the stock its 8th largest position. ClearAlpha Technologies LP owned approximately 0.18% of Amedisys worth $5,416,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in Amedisys by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 3,216,120 shares of the health services provider's stock valued at $291,992,000 after purchasing an additional 10,817 shares during the last quarter. Norges Bank bought a new position in Amedisys during the 4th quarter valued at $83,061,000. Alpine Associates Management Inc. boosted its holdings in Amedisys by 3.2% during the 4th quarter. Alpine Associates Management Inc. now owns 888,120 shares of the health services provider's stock worth $80,632,000 after acquiring an additional 27,403 shares during the last quarter. Wealthfront Advisers LLC bought a new stake in shares of Amedisys in the 4th quarter worth $72,970,000. Finally, Alliancebernstein L.P. lifted its position in shares of Amedisys by 2.0% during the fourth quarter. Alliancebernstein L.P. now owns 677,787 shares of the health services provider's stock valued at $61,536,000 after purchasing an additional 13,587 shares in the last quarter. 94.36% of the stock is owned by institutional investors.

Amedisys Trading Up 0.7 %

Shares of NASDAQ AMED traded up $0.64 during midday trading on Thursday, reaching $94.27. The company had a trading volume of 511,602 shares, compared to its average volume of 405,077. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a one year low of $82.15 and a one year high of $98.95. The firm's fifty day moving average price is $92.17 and its 200-day moving average price is $91.83. The stock has a market cap of $3.09 billion, a PE ratio of 37.41, a price-to-earnings-growth ratio of 1.78 and a beta of 0.89.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. The company had revenue of $594.78 million for the quarter, compared to the consensus estimate of $597.43 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. On average, equities research analysts anticipate that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. Royal Bank of Canada reaffirmed an "outperform" rating and set a $100.00 target price on shares of Amedisys in a research report on Wednesday, April 16th. Stephens reaffirmed an "equal weight" rating and issued a $101.00 price target on shares of Amedisys in a report on Tuesday, March 4th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $100.75.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.